Patent US4187284A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4187284A Expired / Lapsed US ⏱️ 0.0 years remaining

Skeletal imaging kit utilizing triethylene tetramine hexa (methylene phosphonic acid)

Assignee: Merck and Co Inc
•
Filing: 1977-10-03
•
Granted: 1980-02-05
•
Expires: 1997-10-03
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract This invention relates to a novel diagnostic kit for use in radiographic bone scanning. More particularly, it relates to a kit comprising ingredients employed in the preparation of an intravenous injection of a complex of Technetium-99m, stannous ion, and an organic phosphonate identified as triethylene tetramine hexa (methylene phosphonic acid).

Inventors

  • 👤 Richard E. Rolleston
  • 👤 Jacques A. Nadeau

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-26 18:43
CPC Classifications
A; A61; A61K; A61K51/00; A61K51/12; A61K51/1241; A61K2123/00

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 39 words
A kit for the preparation of an injectable solution incorporating Technetium 99m which comprises in a single sterile container a freeze-dried mixture of triethylene tetramine hexa (methylene phosphonic acid) or a water-soluble salt thereof and a water-soluble tin salt.
Claim 2
Dependent Claim 39 words
A kit for the preparation of an injectable solution incorporating Technetium 99m which comprises in a single sterile container a freeze-dried mixture of triethylene tetramine hexa (methylene phosphonic acid) or a water-soluble salt thereof and a water-soluble tin salt.
Claim 3
Dependent Claim 63 words
A kit for the preparation of an injectable solution incorporating Technetium 99m which comprises in a single sterile container a freeze-dried mixture of triethylene tetramine hexa (methylene phosphonic acid) or a water-soluble salt thereof and a water-soluble tin salt in a ratio by weight of from 10-100 parts of triethylene tetramine hexa (methylene phosphonic acid and 1 part of tin as stannous chloride.dihydrate.
Claim 4
Dependent Claim 63 words
A kit for the preparation of an injectable solution incorporating Technetium 99m which comprises in a single sterile container a freeze-dried mixture of triethylene tetramine hexa (methylene phosphonic acid) or a water-soluble salt thereof and a water-soluble tin salt in a ratio by weight of from 10-100 parts of triethylene tetramine hexa (methylene phosphonic acid and 1 part of tin as stannous chloride.dihydrate.
Claim 5
Dependent Claim 33 words
A kit in accordance with claim 2 in which the weight ratio of the components is 40 parts of triethylene tetramine hexa (methylene phosphonic acid) and 1 part of tin as stannous chloride.dihydrate.
Claim 6
Dependent Claim 33 words
A kit in accordance with claim 3 in which the triethylene tetramine hexa (methylene phosphonic acid) is present as the free acid and the tin is added in the form of stannous chloride.dihydrate.
Claim 7
Dependent Claim 10 words
The lead salt of triethylene tetramine hexa (methylene phosphonic acid).
Claim 8
Dependent Claim 10 words
The lead salt of triethylene tetramine hexa (methylene phosphonic acid).

References Cited (Backward Citations)

US3832393A Cited
US3983227A Cited
US3974268A Cited
US4017595A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-02-04 1983-08-06 1984-02-05 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-02-04 1987-08-06 1988-02-05 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-02-04 1991-08-06 1992-02-05 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag